Irinotecan drug eluting beads for use in chemoembolization: In vitro and in vivo evaluation of drug release properties

European Journal of Pharmaceutical Sciences

Volumn 30, Issue 1, 2007, Pages 7-14

  Taylor, Rachel R ^a   Tang, Yiqing ^a   Gonzalez, M Victoria ^a   Stratford, Peter W ^a   Lewis, Andrew L ^a  

^a BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

Chemoembolization; Drug release; In vitro:in vivo correlation; Irinotecan drug eluting beads

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CONTRAST MEDIUM; IOHEXOL; IRINOTECAN; SULFONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BOLUS INJECTION; CATHETER; CHEMOEMBOLIZATION; COMPRESSION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG BINDING; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ELUTING BEAD; DRUG MANUFACTURE; DRUG RELEASE; ELUTION; FEMALE; HEPATIC ARTERY; HYDRATION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; ION EXCHANGE; MALE; MOLECULAR MODEL; NONHUMAN; OPTIMAL DRUG DOSE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; LIVER; MALE; MICROSPHERES; PARTICLE SIZE; SOLUBILITY; SWINE;

EID: 33845446703     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.09.002     Document Type: Article

References (21)

1. Aliberti C., Tilli M., Benea G., and Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Research 26 (2006) 3779-3782
2. Amyot F., Boudy V., Jurski K., Counord J.-L., Guiffant G., Dufaux J., and Chaumeil J.-C. A new experimental method for the evaluation of the release profiles of drug-loaded microbeads designed for embolisation. ITBM-RBM 23 (2002) 285-289
3. Boyd G.E., Adamson A.W., and Myers L.S. The exchange adsorption of ions from aqueous solutions by organic zeolites. II. Kinetics. JACS 69 (1947) 2836-2848
4. Chretien C., Boudy V., Allain P., and Chaumeil J.C. Indomethacin release from ion-exchange microspheres: impregnation with alginate reduces release rate. J. Control. Rel. 96 (2004) 369-378
5. Escoriaza J., Aldaz A., Castellanos C., Calvo E., and Girádles J. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high performance liquid-chromatography: application to clinical pharmacokinetic studies. J. Chromatogr. B: Biomed. Sci. Appl. 740 (2000) 159-168
6. Eyol E., Lewis A.L., Taylor R.R., and Berger M. Chemoembolization of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Proceedings of the AACR 97th Annual Meeting. Washington (2006)
7. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0 (2004), IARC Press, Lyon
8. Giroux M.-F., Baum R.A., and Soulen M.C. Chemoembolization of liver metastases from breast carcinoma. J. Vasc. Interv. Radiol. 15 (2004) 289-291
9. Jantzen G.M., and Robinson J.R. Sustained and controlled-release drug delivery systems. In: Banker G.S., and Rhodes C.T. (Eds). Modern Pharmaceutics. 3rd ed. (1996), Marcel Dekker, Inc., New York
10. Lewis, A.L., Gonzalez, M.V., Hall, B., Willis, S.L., Leppard, S.W., Tang, Y., Palmer, R.R., Wolfenden, L.C., Stratford, P.W., Phillips, G.J., Lloyd, A.W., 2005. Doxorubicin-eluting beads for chemoembolization, Transactions of the Controlled Release Society 32nd Annual Meeting & Expositions, #021.
11. Lewis A.L., Gonzalez M.V., Lloyd A.W., Hall B., Tang Y., Willis S.L., Leppard S.W., Wolfenden L.C., Palmer R.R., and Stratford P.W. DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J. Vasc. Interv. Radiol. 17 (2006) 335-342
12. Lewis A.L., Taylor R.R., Hall B., Willis S.L., and Stratford P.W. Pharmacokinetic and safety study of doxorubicin eluting beads in a porcine model of hepatic arterial embolisation. J. Vasc. Interven. Radiol. 17 (2006) 1335-1343
13. Liu Z., Cheung R., Wu X.Y., Ballinger J.R., Bendayan R., and Rauth A.M. A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres. J. Control. Rel. 77 (2001) 213-224
14. Lorenz K., Brauckhoff M., Behrmann C., Sekulla C., Ukkat J., Brauckhoff K., Gimm O., and Dralle H. Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. Surgery 138 (2005) 986-993
15. Müller H.J., Port R.E., Grubert M., Hilger R.A., Scheulen M., and Mross K. The influence of liver metastases on the pharmacokinetics of doxorubicin- a population-based pharmacokinetic project of the CESAR-APOH. Int. J. Clin. Pharmacol Therapeut. 41 (2003) 598-599
16. O'Toole D., and Ruszniewski P. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. Best Pract. Res. Clin. Gastroenterol. 19 (2005) 585-594
17. Reichenberg D. Properties of ion-exchange resins in relation to their structure. III. Kinetics of exchange. JACS 75 (1953) 589-597
18. Sanz-Altamira P.M., Spence L.D., Huberman M.S., Posner M.R., Steele Jr. G., Perry L.J., and Stuart K.E. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis. Colon. Rectum. 40 (1997) 770-775
19. Stuart K. Chemoembolization in the management of liver tumors. Oncologist 8 (2003) 425-437
20. Tellez C., Benson A.B., Lyster M.T., Talamonti M., Shaw J., Braun M.A., Nemcek Jr. A.A., and Vogelzang R.L. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82 (1998) 1250-1259
21. Wallace S., Carrasco C.H., Charnsangavej C., Richli W.R., Wright K., and Gianturco C. Hepatic artery infusion and chemoembolization the management of liver metastases. Cardiovasc. Intervent. Radiol. 13 (1990) 153-160